Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression-Reference-Cited by-同舟云学术

Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression

Published:2020-05 Issue: Volume:268 Page:188-200
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Tomaz Viviane de Sousa,Chaves Filho Adriano José Maia,Cordeiro Rafaela Carneiro,Jucá Paloma Marinho,Soares Michelle Verde Ramo,Barroso Poliana Noronha,Cristino Larissa Maria Frota,Jiang Wei,Teixeira Antônio Lúcio,de Lucena David F.,Macedo Danielle S.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference93 articles.

1. Therapeutic strategies for treatment of inflammation-related depression;Adzic;Curr. Neuropharmacol.,2018

2. iNOS-mediated nitric oxide production and its regulation;Aktan;Life Sci.,2004

3. Depression and inflammation: disentangling a clear yet complex and multifaceted link;Amodeo;Neuropsychiatry (London),2018

4. Tests for emotionality in rats and mice: a review;Archer;Anim. Behav.,1973

5. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes;Awatsuji;J. Neurosci. Res.,1993

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual dimorphism in neurobehavioural phenotype and gut microbial composition upon long-term exposure to structural analogues of bisphenol-A;Journal of Hazardous Materials;2024-09

2. C3aR in the medial prefrontal cortex modulates the susceptibility to LPS-induced depressive-like behaviors through glutamatergic neuronal excitability;Progress in Neurobiology;2024-05

3. The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression;Immunopharmacology and Immunotoxicology;2024-01-29

4. Microglia and Microbiome-Gut-Brain Axis;Advances in Neurobiology;2024

5. Psychopharmakotherapie mit dem MAO-Hemmer Tranylcypromin Schwerpunkte und Trends aus Theorie und Praxis;Fortschritte der Neurologie · Psychiatrie;2023-11-21